Tofac­i­tinib CAS 477600-75-2

• Iden­ti­fi­ca­tion
• Prop­er­ties
• Safe­ty Data
• Spec­i­fi­ca­tions & Oth­er Information
• Links
• Quick Inquiry

Iden­ti­fi­ca­tion

CAS Number

477600-75-2

Name

Tofac­i­tinib

Syn­onyms

1-piperidine­propa­­nen­i­trile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)- [ACD/​Index Name]
3-{(3R,4R)-4-Methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile
3-{(3R,4R)-4-methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
3-{(3R,4R)-4-Methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanonitril
3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrilato [ACD/IUPAC Name]
3-{(3R,4R)-4-Méthyl-3-[méthyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-pipéridinyl}-3-oxopropanenitrile [French] [ACD/IUPAC Name]
3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropannitril [Ger­man] [ACD/IUPAC Name]
3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
477600-75-2 [RN]
Tasoc­i­tinib
Tofac­i­tinib [INN] [USAN] [Wiki]
Tofac­i­tinib [Span­ish] [INN]
Tofac­i­tinib [French] [INN]
Tofac­i­tinibum [Latin] [INN]
(3r,4r)-Tofacitinib
[477600-75-2]
1259404-17-5, 477600-75-2, 540737-29-9
1-Piperidine­propa­­nen­i­trile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-b-oxo-, (3R,4R)-
1-piperidine­propa­­nen­i­trile, 4-methyl-3-(methyl-7h-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3r,4r)-
3-((3R,4r)-4-methyl-3-(methyl (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRRO­LO[2,3-D]PYRIM­IDIN-4YL)AMINO)PIPERIDIN-1-YL)-3-OXO­PROPA­NEN­I­TRILE
3-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile(wxc01414)
3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)-1-piperidinyl]-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)-1-piperidyl]-3-oxo-propanenitrile
3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)piperidin-1-yl]-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)piperidin-1-yl]-3-oxo-propanenitrile
3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
3-keto-3-[(3R,4R)-4-methyl-3-(methyl-(7H-pyrrolo[3,2-e]pyrimidin-4-yl)amino)-1-piperidyl]propionitrile
87LA6FU830
937669-80-2 [RN]
ck2inhibitor10
CP-690,550|CP-690550|tasocitinib|Xeljanz®
cp6905503-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
GS-6106
https://​www​.ebi​.ac​.uk/​c​h​e​b​i​/​s​e​a​r​c​h​I​d​.​d​o​?​c​h​e​b​i​I​d​=​C​H​E​B​I​:​7​1​200
MFCD11035919 [MDL num­ber]
MFCD22628813 [MDL num­ber]
MI1
tasoc­i­tinib (cp 690550)
Tasoc­i­tinib ; Tofac­i­tinibum
Tasoc­i­tinib ;CP-690550 ;CP 690550 ;CP690550
tasocitinib???tofacitinib???cp 690550
Tofac­i­tinib (CP-690550, Tasoc­i­tinib)
Tofac­i­tinib (CP-690550,Tasoc­i­tinib)
tofacitinib(cp-690550)
tofacitinib(cp-690550,tasocitinib)
tofacitinib,cp-690550
tofac­i­tinibum
UNII :87LA6FU830
UNII-87LA6­­FU830
Xel­janz®
тофацитиниб
توفاسيتينيب
托法替布

SMILES

C[C@@H]1CCN(C[C@@H]1N(C)c2c3cc[nH]c3ncn2)C(=O)CC#N

Std­InChI

InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1

Std­InChIKey

UJLAWZD­WD­VH­­WOW-YPMH­NX­CE­SA-N

Mol­e­c­u­lar Formula

C₁₆H₂₀N₆O

Mol­e­c­u­lar Weight

312.370

MDL Number

MFCD11035919

Prop­er­ties

Appear­ance

White pow­der

Safe­ty Data

RIDADR 

NONH for all modes of transport

WGK Germany

3

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Tofac­i­tinib CAS 477600-75-2

Iden­ti­fi­ca­tion Methods

HNMR, HPLC

Avail­able document

GMP, DMF

Puri­ty

98% min

Shelf Life

2 years

Stor­age

Under room tem­per­a­ture away from light

Known Appli­ca­tion

Often used as nucleotide antivi­ral drugs.

Links

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​t​o​f​a​c​i​t​i​n​i​b​-​c​a​s​-​4​7​7​6​0​0​-​7​5​-2/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).